Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/4964
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDevipriya, S-
dc.contributor.authorVijaya, M.S-
dc.date.accessioned2024-04-01T05:36:54Z-
dc.date.available2024-04-01T05:36:54Z-
dc.date.issued2024-02-25-
dc.identifier.urihttps://link.springer.com/chapter/10.1007/978-981-99-7820-5_7-
dc.description.abstractIC50 prediction for neurodegenerative disorders like amyotrophic lateral sclerosis is crucial in biomedical studies. Traditional machine learning models use molecular descriptors for IC50 prediction where most of the descriptors created by different tools are irrelevant and undefined. Hence, graph convolutional neural network, a deep learning algorithm is used in this paper for building more accurate IC50 prediction model based on the structural properties of drug molecules in graph format. The work is implemented with 32 protein targets of amyotrophic lateral sclerosis disorder. IC50 prediction is made by collecting canonical SMILES and their corresponding IC50 values of 2100 drugs from the ChEMBL databases. Featurization and conversion of SMILES to molecular graphs are done by the Deepchem library. The library is used for dataset creation and model building. The results show that the proposed GCNN model with their fine-tuned hyperparameters achieves a prediction rate of 73%.en_US
dc.language.isoen_USen_US
dc.publisherSpringer Linken_US
dc.subjectAmyotrophic lateral sclerosisen_US
dc.subjectIC50en_US
dc.subjectGraph convolutional neural networken_US
dc.subjectSMILESen_US
dc.subjectPredictionen_US
dc.titleGRAPH CONVOLUTIONAL NEURAL NETWORK FOR IC50 PREDICTION MODEL USING AMYOTROPHIC LATERAL SCLEROSIS TARGETSen_US
dc.typeOtheren_US
Appears in Collections:4. Conference Paper (12)



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.